Tadao Ishida

6.4k total citations · 2 hit papers
135 papers, 4.4k citations indexed

About

Tadao Ishida is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Tadao Ishida has authored 135 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 59 papers in Hematology and 45 papers in Oncology. Recurrent topics in Tadao Ishida's work include Multiple Myeloma Research and Treatments (50 papers), Protein Degradation and Inhibitors (20 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers). Tadao Ishida is often cited by papers focused on Multiple Myeloma Research and Treatments (50 papers), Protein Degradation and Inhibitors (20 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers). Tadao Ishida collaborates with scholars based in Japan, United States and Belgium. Tadao Ishida's co-authors include Dmitry I. Gabrilovich, David P. Carbone, Tsunehiro Oyama, Sorena Nadaf, Sophia Ran, Vladimir Kravtsov, Lawrence D. Kerr, Kohzoh Imai, Susumu Ikehara and Yuji Hinoda and has published in prestigious journals such as Physical Review Letters, The Journal of Experimental Medicine and Blood.

In The Last Decade

Tadao Ishida

116 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo

1998 784 citations Tadao Ishida et al. profile →
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo

1998 734 citations Tadao Ishida et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tadao Ishida Japan	26	2.0k	1.7k	1.7k	600	472	135	4.4k
Paul J. Neeson Australia	33	1.9k 0.9×	2.4k 1.4×	1.4k 0.8×	757 1.3×	274 0.6×	144	4.2k
Guenther Gastl Austria	38	1.4k 0.7×	2.2k 1.3×	1.6k 1.0×	589 1.0×	669 1.4×	110	4.9k
Lubor Borsig Switzerland	43	1.7k 0.8×	2.1k 1.3×	3.3k 2.0×	892 1.5×	942 2.0×	99	7.1k
Jean‐Luc Teillaud France	41	2.8k 1.4×	1.5k 0.9×	2.0k 1.2×	396 0.7×	162 0.3×	164	5.7k
Sebastian Kobold Germany	36	2.7k 1.3×	3.3k 1.9×	1.7k 1.0×	297 0.5×	370 0.8×	141	5.5k
Salvatore Venuta Italy	45	1.4k 0.7×	1.6k 0.9×	2.2k 1.3×	656 1.1×	757 1.6×	137	5.1k
Nathalie Bonnefoy France	39	2.1k 1.1×	1.3k 0.7×	1.7k 1.0×	333 0.6×	292 0.6×	102	4.4k
Elke Pogge von Strandmann Germany	36	2.0k 1.0×	1.4k 0.8×	2.0k 1.2×	185 0.3×	753 1.6×	114	4.4k
John L. Magnani United States	38	1.5k 0.7×	1.1k 0.7×	4.0k 2.4×	975 1.6×	295 0.6×	153	6.4k
Marina Fabbi Italy	36	3.5k 1.7×	1.5k 0.9×	1.2k 0.7×	205 0.3×	286 0.6×	93	5.2k

Countries citing papers authored by Tadao Ishida

Since Specialization

Citations

This map shows the geographic impact of Tadao Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadao Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadao Ishida more than expected).

Fields of papers citing papers by Tadao Ishida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadao Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadao Ishida. The network helps show where Tadao Ishida may publish in the future.

Co-authorship network of co-authors of Tadao Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Tadao Ishida. A scholar is included among the top collaborators of Tadao Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadao Ishida. Tadao Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kikuchi, Taku, Hitoshi Sawada, Yu Abe, et al.. (2025). Can baseline cytomegalovirus IgG titers predict cytomegalovirus reactivation after ide-cel therapy?. Blood Advances. 9(18). 4716–4719.

Iida, Shinsuke, Kazutaka Sunami, Shigeki Ito, et al.. (2025). Phase 1 study of talquetamab, a humanized GPRC5D x CD3 bispecific antibody, in Japanese patients with relapsed/refractory MM. International Journal of Hematology. 122(3). 421–433.

Ishida, Tadao, Kiyoshi Ando, Rikio Suzuki, et al.. (2023). Phase 2 results of idecabtagene vicleucel (ide-cel, bb2121) in Japanese patients with relapsed and refractory multiple myeloma. International Journal of Hematology. 117(5). 729–737. 15 indexed citations

Ishida, Tadao, et al.. (2023). Evaluating process utilities for the treatment burden of chemotherapy in multiple myeloma in Japan: a time trade-off valuation study. Journal of Medical Economics. 26(1). 565–573. 1 indexed citations

Handa, Hiroshi, et al.. (2023). Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database. PLoS ONE. 18(4). e0283931–e0283931. 7 indexed citations

Kawano, Yawara, Kihyun Kım, Chang Ki Min, et al.. (2023). Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis. Clinical Lymphoma Myeloma & Leukemia. 23(10). e360–e367.

Iida, Shinsuke, Tadao Ishida, Toshihiro Miyamoto, et al.. (2022). MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantation. International Journal of Hematology. 116(3). 411–422. 1 indexed citations

Ri, Masaki, Kenshi Suzuki, Tadao Ishida, et al.. (2022). Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE‐1 (phase 2) Japanese cohort. Cancer Science. 113(12). 4267–4276. 12 indexed citations

Iida, Shinsuke, et al.. (2020). Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) – a focus on healthcare resource utilization and cost. International Journal of Hematology. 113(2). 271–278. 1 indexed citations

10.

Iida, Shinsuke, Takashi Watanabe, Morio Matsumoto, et al.. (2019). Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study. Cancer Science. 110(9). 2924–2932. 6 indexed citations

11.

Ishida, Tadao. (2013). [Triplets therapy for the patients of multiple myeloma].. PubMed. 71(9). 1691–6.

12.

Nojima, Masanori, Reo Maruyama, Hiroshi Yasui, et al.. (2009). Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma. Clinical Cancer Research. 15(13). 4356–4364. 53 indexed citations

13.

Tanaka, Ayako, Tôru Nakamura, Takashi Koike, et al.. (2008). The Kii Bifurcation Current and Cold Eddy in Kii Channel. Oceanography in Japan. 17(3). 193–204.

14.

Sonoda, Tomoko, Tadao Ishida, Hajime Sakai, et al.. (2005). A case-control study of multiple myeloma in Japan: association with occupational factors.. PubMed. 6(1). 33–6. 21 indexed citations

15.

Hinoda, Yuji, Shigeru Sasaki, Tadao Ishida, & Kohzoh Imai. (2004). Monoclonal antibodies as effective therapeutic agents for solid tumors. Cancer Science. 95(8). 621–625. 49 indexed citations

16.

Yoshimoto, Mitsuru, Saho Honda, Tadao Ishida, et al.. (2002). The Antisense Approach in Amyloid Light Chain Amyloidosis: Identification of Monoclonal Ig and Inhibition of Its Production by Antisense Oligonucleotides in In Vitro and In Vivo Models. The Journal of Immunology. 169(7). 4039–4045. 17 indexed citations

17.

Imai, Kohzoh, Shigeo Aoki, Tadao Ishida, et al.. (1991). Evaluation of thermography in the patients with collagen disease receiving infusion of lipo-PGE1.. Drug Delivery System. 6(5). 387–393. 1 indexed citations

18.

Shiro, M., Ichiro Yoshino, Tadao Ishida, et al.. (1990). Effect of an anti-CD3 antibody on the culture of lymphokine activated killer cells from human lymph node lymphocytes. 3(3). 154–158. 1 indexed citations

19.

Ishida, Tadao, et al.. (1989). A case of adult T-cell leukemia (ATL) developed acute hepatic failure as the initial manifestation.. Kanzo. 30(9). 1026–1031. 1 indexed citations

20.

Kuramochi, Taichi, et al.. (1987). Cross-reactivity between human and feline Ia antigens, using a monoclonal antibody HLA-D.m1.. PubMed. 48(2). 186–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact